{
Novartis AG

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-272025-03-272025-03-312025-03-31115118866442200
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-272025-03-272025-03-312025-03-3142218866442200
Download SVG
Download PNG
Download CSV

novartis ag faces challenges as ub s downgrades outlook on pharmaceutical sales

Novartis AG is a leading global pharmaceutical company, with sales primarily in oncology (29.3%), immunology (18.5%), and cardiovascular, renal, and metabolic diseases (17%). The company operates over 30 production sites worldwide, with sales distributed across Europe (30.9%), the USA (42%), and Asia-Africa-Australasia (20%). Additionally, 25.8% of sales come from contract manufacturing.
Zonebourse
United States Dollar Novartis AG USA Show more
Business & Industry, Market Report
07:37 13.02.2025

ubs downgrades novartis stock rating and lowers price target amid challenges

UBS has downgraded Novartis from Buy to Neutral, lowering the price target from CHF111 to CHF104, citing concerns over upcoming patent expirations that could slow growth. Despite a strong product portfolio and solid financial health, the company faces challenges that may impact its market performance by mid-2025. Additionally, Novartis is nearing EU antitrust approval for its $16.5 billion acquisition of Catalent, which could enhance its manufacturing capabilities.
Investing.com South Africa
United States Dollar Euro Swiss Franc Novartis AG USA CHE Matthew Weston Show more
Business & Industry, Market Report
07:22 13.02.2025

ubs downgrades novartis shares amid patent expirations and market challenges

UBS has downgraded Novartis shares from Buy to Neutral, lowering the target price from CHF 111 to CHF 104, citing concerns over upcoming patent expirations that could slow growth. Despite a strong product portfolio and solid financial health, the company faces challenges that may impact its stock performance beyond mid-2025. Additionally, Novartis is nearing EU antitrust approval for its $16.5 billion acquisition of Catalent, which aims to enhance its manufacturing capabilities.
Investing.com Deutsch
United States Dollar Euro Swiss Franc Novartis AG CHE Matthew Weston Show more
Business & Industry, Market Report
07:04 13.02.2025

ubs downgrades novartis to neutral with price target of chf104

UBS analyst Matthew Weston has downgraded Novartis (NOVN:SW) (NYSE: NVS) from Buy to Neutral, setting a new price target of CHF 104.00. This change reflects a shift in the firm's outlook on the pharmaceutical giant as of February 13, 2025.
StreetInsider.com
Swiss Franc Novartis AG CHE Matthew Weston
Finance & Economy, Market Report
06:15 13.02.2025

swiss bank shares face downgrades as UBS receives mixed analyst ratings

Swiss bank shares experienced mixed downgrades, with Deutsche Bank upgrading UBS to a BUY rating and a price target of CHF 37, while Kepler Cheuvreux downgraded Julius Baer to HOLD with a reduced target of CHF 58. The market showed slight gains for UBS and Novartis, while Landis+Gyr faced a significant drop following a profit warning.
cash.ch
United States Dollar Euro Swiss Franc Julius Bär Gruppe AG Novartis AG CHE Christina Johansson Stefan Bollinger
Finance & Economy, Market Report
08:05 11.02.2025

global markets react to trade tensions and rising oil prices

US President Trump has imposed a 25% tariff on steel and aluminum imports, prompting countermeasures from the EU. While the currency market showed little reaction, gold prices surged amid rising fears of financial turmoil. Asian markets remained cautious, with expectations of a trade agreement between the US and China still high.
cash.ch
United States Dollar Euro KERING NVIDIA Corporation Microsoft Corporation Alphabet Inc. RICHEMONT, Intellectual Property Services Novartis AG Rockwell Automation, Inc. McDonald's Corp SGS SA BioVersys N JPN CHN HKG USA Christoph Rieger Donald Trump Ursula von der Leyen Dennis Dick Show more
Finance & Economy, Market Report
06:10 11.02.2025

analysts update recommendations and price targets for major european companies

Analysts have made several notable changes to their recommendations and price targets for various companies. Adecco Group was downgraded by Deutsche Bank, while Ahold Delhaize saw its target raised by KBC Securities. Anheuser-Busch Inbev received an upgrade from ING Bank, and Ferrari's target was increased by Jefferies. Other significant adjustments include downgrades for Porsche and Fevertree Drinks, alongside upgrades for companies like Victrex and Soitec.
Zonebourse
British Pound Sterling Swiss Franc Euro United States Dollar Norwegian Krone Credit Agricole Roche Holding AG Vinci SA L'Oréal Spectris plc Rational AG Aurubis AG BPER Banca SpA Victrex plc Fagerhult Group AB Nordic Semiconductor ASA Safestore Holdings Plc BNP Paribas SA Safran S.A. (ADRs) Technip Energies N.V. Soitec SA Anheuser-Busch InBev SA/NV Marimekko Oyj Novartis AG Interroll Holding AG X-FAB Silicon Foundries SE Outokumpu Oyj Heineken N.V. Pluxee A Iveco Group N.V. International Consolidated Airlines Group S.A. Koninklijke Ahold Delhaize N.V. The Swatch Group AG Ferrari N.V. UBS Group AG Kongsberg Gruppen ASA Adecco Group AG Atea ASA Fevertree Drinks PLC Ørsted A/S Pennon Group Plc Hermes International Laboratorios Farmaceuticos Rovi, S.A. NOR DEU FRA GBR SWE ITA DNK CHE NLD Show more
Business & Industry, Market Report
08:44 10.02.2025

Swiss stock market dips as labor data and tech sector woes weigh down indices

The Swiss stock market experienced a slight decline, with the SMI closing 0.24% lower at 12,593.34 points, marking its first loss after six weeks of gains. Swisscom and Holcim saw gains amid merger rumors, while financial stocks like Julius Baer and Partners Group faced significant losses. The US labor market data influenced investor sentiment, with employment growth slightly below expectations but a drop in the unemployment rate to 4%.
Finanz und Wirtschaft
United States Dollar Euro Swiss Franc CVC Capital Partners plc Lemonade, Inc. ABB Ltd Axon Partners Group, S.A. Iliad SA Hoffmann-La Roche AG Swiss Re AG BioVersys AG SGS SA Vodafone Italia S.p.A. Holcim AG Adecco Group AG Julius Bär Gruppe AG Swisscom AG Novartis AG Telecom Italia S.p.A. DocMorris AG Nestlé S.A. Zurich, Agence générale Christian Meier SA EMS-CHEMIE HOLDING AG Geberit AG Vivendi SE Swiss Life Holding AG CHE Thomas Gitzel Xavier Niel Show more
Finance & Economy, Market Report
07:52 07.02.2025

Swiss stock market gains momentum led by UBS and Holcim shares

Swiss equities showed slight gains, with the SMI rising 0.4% to 12,624 points, supported by strong performances from Holcim (+3.7%) and UBS (+3.6%). Optimism among Swiss entrepreneurs and a positive impulse from the Bank of England contributed to the market's mood, despite losses in major pharmaceutical stocks Roche (-1.2%) and Novartis (-0.9%).
MarketScreener
United States Dollar Swiss Franc Holcim AG Sika AG Lonza Group AG Zurich Insurance Group AG Sonova R Novartis AG Hoffmann-La Roche AG CHE Show more
Finance & Economy, Market Report
17:54 06.02.2025

Swiss stock market maintains upward trend amid trade war concerns

The Swiss stock market maintained its upward momentum at midday, with the SMI up 0.44% as concerns over the US-China trade conflict lingered. UBS led gains at +1.9%, while Temenos rose 1.4% after selling its fund management unit. However, Leonteq faced an 8.4% drop following regulatory sanctions.
agefi.com
United States Dollar British Pound Sterling Euro Swiss Franc Leonteq AG Swiss Prime Site AG StarragTornos Group AG Novartis AG Swisscom AG Hoffmann-La Roche AG Logitech International S.A. Nestlé S.A. Temenos AG Kuehne + Nagel International AG Compagnie Financière Tradition SA CHE GBR DEU Ricardo Evangelista Walter Fust Philip Jefferson Show more
Finance & Economy, Market Report
11:41 06.02.2025
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Banking Regulations Finance Mergers & Acquisitions Global Financial Events Central Bank Actions Retail and Consumer Goods CEO Changes GDP Growth & Recession Forecasts Global Trade Developments Financial Scams and Security Industry Mergers & Acquisitions Inflation and Monetary Impact Market Analysis and Predictions Government Policies Government Economic Policies Supply Chain Management Startups & Entrepreneurship Domestic Politics
Countries:
USA CHN GBR FRA DEU CHE CAN JPN ITA IND MEX AUS HKG ESP KOR ARE RUS BRA IRL ARG
Companies:
The Goldman Sachs Group, Inc. JPMorgan Chase & Co. Tesla, Inc. Apple Inc. Bank of America Corporation Barclays PLC Wells Fargo & Company Citigroup Inc. Deutsche Bank Money Market PP Morgan Stanley Huawei Technologies CO. Ltd. Lloyds Banking Group plc Microsoft Corporation Credit Suisse Strategic Income I NVIDIA Corporation AXA SA Safran SA Banco Santander, S.A. Novartis AG End Federal Reserve USD
Currencies:
United States Dollar Euro Chinese Yuan British Pound Sterling Swiss Franc Japanese Yen Indian Rupee Russian Ruble Australian Dollar Canadian Dollar United Arab Emirates Dirham Indonesian Rupiah Saudi Riyal South Korean Won Danish Krone Offshore Chinese Yuan Hong Kong Dollar Mexican Peso Malaysian Ringgit Vietnamese Đồng
People:
Donald Trump Elon Musk Goldman Sachs Brad Schimel Troy L Rohrbaugh Sabrina Meng Will Hardcastle Jerome Powell Warren Buffett Robin Leopold Kirsty Roth Klaus Moosmayer Solita Marcelli Bruno Marxer Ulrike Hoffmann-Burchardi Susan P. Crawford Stacey Friedman Joe Biden Sara Wechter Christian Sewing

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.